Unique ID issued by UMIN | UMIN000026086 |
---|---|
Receipt number | R000029973 |
Scientific Title | Factors Associating Reluctance to Initiate or Continue Oral Antihyperglycemic Agent (OAHA) Treatments in Type 2 Diabetes Mellitus Patients in Japan: Observational, Cross-sectional, Patient-Reported and Web-Based Survey |
Date of disclosure of the study information | 2017/02/18 |
Last modified on | 2019/08/20 17:23:52 |
Factors Associating Reluctance to Initiate or Continue Oral Antihyperglycemic Agent (OAHA) Treatments in Type 2 Diabetes Mellitus Patients in Japan: Observational, Cross-sectional, Patient-Reported and Web-Based Survey
Factors Associating Reluctance to Initiate or Continue Oral Antihyperglycemic Agent (OAHA) Treatments in Type 2 Diabetes Mellitus Patients in Japan: Observational, Cross-sectional, Patient-Reported and Web-Based Survey
Factors Associating Reluctance to Initiate or Continue Oral Antihyperglycemic Agent (OAHA) Treatments in Type 2 Diabetes Mellitus Patients in Japan: Observational, Cross-sectional, Patient-Reported and Web-Based Survey
Factors Associating Reluctance to Initiate or Continue Oral Antihyperglycemic Agent (OAHA) Treatments in Type 2 Diabetes Mellitus Patients in Japan: Observational, Cross-sectional, Patient-Reported and Web-Based Survey
Japan |
Type 2 diabetes mellitus
Medicine in general | Endocrinology and Metabolism |
Others
NO
To describe barriers to drug treatment of T2DM among the drug naive and treated patient groups.
Others
Barriers to drug treatment of T2DM
Exploratory
Pragmatic
Not applicable
Questionnaire items for barriers to T2DM treatment initiation in drug-naive T2DM group and continuation or adherence for non drug-naive T2DM group.
Observational
20 | years-old | <= |
Not applicable |
Male and Female
Patients age 20+
Patients who receive healthcare in Japan
Patients must self-report being either:
1.Diagnosed T2DM and have seen physician in past 6 months, recommended D&E, but not started any treatment for T2DM including OAHA,
2.Suspected T2DM patients who have seen a physician in the past 6 months and were recommended D&E due to their high blood glucose/HbA1c, but have not started any treatment for T2DM including OAHA,
3.Diagnosed T2DM patients who have seen a physician in the past 6 months are currently on OAHA monotherapy, and
4.Diagnosed T2DM patients who initiated OAHA treatment but then discontinued (patient reported basis)
Able to read and understand Japanese and provide informed consent
Diagnosed with Type 1 Diabetes Mellitus
Pregnant
Drug-induced T2DM
(Above listed 1 & 2) told by physician already being well-controlled on their glycemic levels and currently no need to engage in D&E therapy
625
1st name | Takekazu |
Middle name | |
Last name | Kubo |
MSD K.K.
Medical Affairs
102-8667
1-13-12 Kudan-kita, Chiyoda-ku, Tokyo
03-6272-1000
ldgproject@merck.com
1st name | Takekazu |
Middle name | |
Last name | Kubo |
MSD K.K.
Medical Affairs
102-8667
1-13-12 Kudan-kita, Chiyoda-ku, Tokyo
03-6272-1000
ldgproject@merck.com
MSD K.K.
MSD K.K.
Profit organization
Kitamachi Clinic
1-1-3 Kitamachi Kichijoji Musashino-city Tokyo
03-6779-8166
shingo-namiki@j-smo.com
NO
2017 | Year | 02 | Month | 18 | Day |
Unpublished
Completed
2017 | Year | 01 | Month | 24 | Day |
2016 | Year | 11 | Month | 22 | Day |
2017 | Year | 02 | Month | 18 | Day |
2018 | Year | 08 | Month | 31 | Day |
Recruitment with NHWS patient panel
2017 | Year | 02 | Month | 10 | Day |
2019 | Year | 08 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029973
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |